Home  >  News
  Exosome Sciences initiates IRB approved research study to detect chronic traumatic encephalopathy in former NFL players,   March 24, 2018
  Novartis phase III data shows siponimod significantly improves outcomes in patients with secondary progressive MS,   March 24, 2018
  Edwards completes patient enrollment in PARTNER 3 trial of SAPIEN 3 valve to treat severe aortic stenosis,   March 23, 2018
  AbbVie, IMF partner to study role of genetic mutation in outcomes of patients with MM,   March 23, 2018
  GSK initiates phase III study of Benlysta in combo with rituximab in systemic lupus erythematosus,   March 22, 2018
  Arena Pharma announces positive results from phase 2 OASIS trial for etrasimod in patients with ulcerative colitis,   March 21, 2018
  eTheRNA to begin phase 1b study of TriMix mRNA-based cancer specific immunotherapy, ECI-006 in melanoma,   March 21, 2018
  Genentech announces phase III IMpower131 study of Tecentriq plus chemotherapy to treat advanced squamous NSCLC meets co-primary endpoint,   March 21, 2018
  Favorable safety profile of Pradaxa confirmed in large prospective real-world analysis,   March 21, 2018
  Regeneron announces phase 3 PANORAMA trial evaluating Eylea in moderately severe to severe NPDR met its 24-week primary endpoint,   March 20, 2018
  Elthera reports positive results from L1CAM antibodies in preclinical models of pancreatic & ovarian carcinomas,   March 20, 2018
  NIH sponsored phase 2 studies of H7N9 influenza vaccine clinical trials begin,   March 19, 2018
  AMO Pharma presents positive results from phase 2 study of AMO-02 in congenital, childhood onset myotonic dystrophy type 1 at MDA conference,   March 17, 2018
  There should be a Clinical Establishment Act for Maharashtra: Dr Deepak Sawant,   March 16, 2018
  Inovio Pharma announces positive results from phase 1 study of DNA immunotherapy to treat HBV infection,   March 16, 2018
  PharmaJet announces positive results from phase 1 trial of hantavirus vaccines to prevent hemorrhagic fever with renal syndrome,   March 15, 2018
  MYR Pharma completes phase 2b study of Myrcludex B in chronic hepatitis Delta,   March 14, 2018
  MorphoSys announces updated data from phase 2 L-MIND study of MOR208 plus lenalidomide in patients with r/r DLBCL,   March 14, 2018
  AstraZeneca announces CVD-REAL study of patients with T2D confirms CV benefits associated with SGLT-2 inhibitors,   March 13, 2018
  BMS, Pfizer present findings from largest RWD analysis of NVAF patients receiving direct oral anticoagulants at ACC scientific session,   March 13, 2018

cphikorea_150x60_saffron media
Copyright © 2016 Saffron Media Pvt. Ltd |